Table 1:
Approach | Model | Phenotype | Ref |
---|---|---|---|
ASO | St Thomas’ | Targeting FXII and FXI with high level knockdown equally protective | 18 |
KO | IVC stenosis | FXII deficiency, but not FXI deficiency, protective | 19 |
siRNA | FVEI | Targeting FXII more protective than FXI for intermediate level knockdown | 61 |
KO | IVC stenosis | FXII and FXI deficiency equally protective | Current Study |
KO | IVC stasis | FXII and FXI deficiency not protective | Current Study |
KO | FVEI | FXII and FXI deficiency equally protective | Current Study |
antisense oligonucleotide, ASO; inferior vena cava, IVC; short interfering RNA, siRNA, femoral vein electrolytic injury, FVEI; knockout, KO